Page last updated: 2024-11-04

sulfasalazine and Acute Promyelocytic Leukemia

sulfasalazine has been researched along with Acute Promyelocytic Leukemia in 1 studies

Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.

Research Excerpts

ExcerptRelevanceReference
"We report a case of acute promyelocytic leukemia (APL) following ulcerative colitis (UC)."1.29[Acute promyelocytic leukemia following ulcerative colitis]. ( Ikeda, T; Miyanishi, E; Nagaya, S; Nakase, K; Suzuki, Y; Tamaki, S; Tanigawa, M; Tsuji, K, 1995)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suzuki, Y1
Nakase, K1
Nagaya, S1
Tamaki, S1
Tanigawa, M1
Ikeda, T1
Tsuji, K1
Miyanishi, E1

Other Studies

1 other study available for sulfasalazine and Acute Promyelocytic Leukemia

ArticleYear
[Acute promyelocytic leukemia following ulcerative colitis].
    [Rinsho ketsueki] The Japanese journal of clinical hematology, 1995, Volume: 36, Issue:7

    Topics: Adult; Anticoagulants; Colitis, Ulcerative; Disseminated Intravascular Coagulation; Fatal Outcome; G

1995